dermatan sulfate has been researched along with Diabetes Mellitus, Type 2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frölich, M; Lemkes, HH; van der Meer, FJ; van der Pijl, JW; van der Woude, FJ; Van Es, LA | 1 |
| Cirillo, R; Mameli, G; Mamusa, AM; Marongiu, F; Mascia, F; Paoletti, P | 1 |
1 trial(s) available for dermatan sulfate and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Effect of danaparoid sodium on proteinuria, von Willebrand factor, and hard exudates in patients with diabetes mellitus type 2.
Topics: Adult; Aged; Analysis of Variance; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Retinopathy; Double-Blind Method; Drug Combinations; Endothelium, Vascular; Exudates and Transudates; Female; Follow-Up Studies; Heparitin Sulfate; Humans; Kidney Function Tests; Male; Middle Aged; Proteinuria; Reference Values; Statistics, Nonparametric; von Willebrand Factor | 1999 |
1 other study(ies) available for dermatan sulfate and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Dermatan sulphate, heparin cofactor II, and F1+2 peptide in non-insulin-dependent diabetes mellitus.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Dermatan Sulfate; Diabetes Mellitus, Type 2; Female; Heparin Cofactor II; Humans; Male; Middle Aged; Peptide Fragments; Prothrombin; Retrospective Studies; Vascular Diseases | 2000 |